Stem Cell Company Failed To Show Patent Invalid, Federal Circuit Agrees
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on March 4 affirmed a decision from the U.S. Patent Trial and Appeal Board (PTAB), agreeing that an appellant stem...To view the full article, register now.
Already a subscriber? Click here to view full article